FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 902. Misbranding of ampuls of sodium salicylate and sodium iodide with colchicine, and adulteration and misbranding of thyroid and ovarian compound. U. S. v. Kenneth Gaylord Ziegler (Ziegler Pharmacal Co.). Plea of guilty. Fine, $450. Payment of fine suspended. ✖Remove constraint Titles: 902. Misbranding of ampuls of sodium salicylate and sodium iodide with colchicine, and adulteration and misbranding of thyroid and ovarian compound. U. S. v. Kenneth Gaylord Ziegler (Ziegler Pharmacal Co.). Plea of guilty. Fine, $450. Payment of fine suspended. Defendants Kenneth Gaylord Ziegler, trading as Ziegler Pharmacal Company, Buffalo, N. Y. ✖Remove constraint Defendants: Kenneth Gaylord Ziegler, trading as Ziegler Pharmacal Company, Buffalo, N. Y. Adjudicating Courts Western District of New York ✖Remove constraint Adjudicating Courts: Western District of New York

Refine by:

  • 902. Misbranding of ampuls of sodium salicylate and sodium iodide with colchicine, and adulteration and misbranding of thyroid and ovarian compound. U. S. v. Kenneth Gaylord Ziegler (Ziegler Pharmacal Co.). Plea of guilty. Fine, $450. Payment of fine suspended.1

  • Kenneth Gaylord Ziegler, trading as Ziegler Pharmacal Company, Buffalo, N. Y.1